ANGIOTENSIN II AND MYOCARDIAL INFARCTION

ANGIOTENSIN II AND MYOCARDIAL INFARCTION

The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II participates in development of acute myocardial infarction (MI) in patients with atherosclerosis. It contributes to inflammation of vessel intimae, oxidative stress, cells apoptosis, matrix remodeling,...

Full description

Bibliographic Details
Main Authors:	O. P. Shevchenko, А. О. Shevchenko
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	angiotensin ii myocardial infarction ace inhibitor lisinopril
Online Access:	https://www.rpcardio.online/jour/article/view/1121

Similar Items

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Effects of lisinopril on experimental ischemia in rats. Influence of infarct size
by: Leonardo A. M. Zornoff, et al.
Published: (1999-10-01)

SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT
by: N. A. Jaiani
Published: (2016-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
by: Hye-Jin Park, et al.
Published: (2022-01-01)

Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry
by: Chan Soon Park, et al.
Published: (2022-08-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors
by: A. S Galyavich
Published: (2010-03-01)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
by: Rinaldo Bellomo, et al.
Published: (2020-02-01)

Renin-angiotensin and kallikrein-kinin systems in diabetic retinopathy
by: Igić Rajko
Published: (2019-01-01)

Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives
by: Attila Nagy, et al.
Published: (2023-12-01)

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES
by: N. A. Dzhaiani
Published: (2015-09-01)

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY
by: O. G. Zaylobidinov, et al.
Published: (2016-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
by: Nagaraja Moorthy, et al.
Published: (2021-02-01)

The renin-angiotensin system and its blockers
by: Igić Rajko, et al.
Published: (2014-01-01)

Influence of myocardial infarction on changes in the expression of angiotensin type 1 receptor in the rat prostate
by: Kamila Domińska, et al.
Published: (2011-10-01)

Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart
by: Vimal Agrawal, et al.
Published: (2016-11-01)

THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR?
by: S. Yu. Martsevich
Published: (2016-01-01)

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
by: Daniela-Carmen Ababei, et al.
Published: (2023-09-01)

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
by: Shu Jin, et al.
Published: (2023-02-01)

A1166C POLYMORPHISM OF THE GENE FOR ANGIOTENSIN II RECEPTOR 1ST TYPE AND ENDOTHELIAL DYSFUNCTION IN MEN WITH A HISTORY OF MYOCARDIAL INFARCTION IN YOUNG AGE
by: O. A. Berkovich, et al.
Published: (2000-12-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

A rare presentation of angioedema with isolated retropharyngeal and supraglottic involvement
by: H. Patel, et al.
Published: (2019-01-01)

Effects of inhibition of the renin-angiotensin system on hypertension-induced target organ damage: clinical and experimental evidence
by: Maria Rosaria De Luca, et al.
Published: (2021-02-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
by: Yong Hoon Kim, et al.
Published: (2020-01-01)

The effect of aspirin therapy on the plasma renin activity in myocardial infarction
by: M.H Ansari, et al.
Published: (1995-07-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2022-12-01)

ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure
by: Wolf-Stephan Rudi, et al.
Published: (2021-03-01)

Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trial
by: Salvatore Corrao, et al.
Published: (2006-05-01)

COMPARATIVE EFFICIENCY OF THE COMBINED THERAPY IN PATIENT’S WITH ARTERIAL HYPERTENSION
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

COMPARATIVE EFFICIENCY OF THE COMBINED THERAPY IN PATIENT’S WITH ARTERIAL HYPERTENSION
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
by: Akif Arslan, et al.
Published: (2016-01-01)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
by: Oghenemega Okoloko, et al.
Published: (2021-11-01)

Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients
by: Wiam Hmimech, et al.
Published: (2017-12-01)

Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study
by: Dorien M. C. F. Sluijsmans, et al.
Published: (2021-05-01)

Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension
by: Giovanna Castoldi, et al.
Published: (2021-12-01)

Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up
by: Xuhe Gong, et al.
Published: (2018-12-01)